Yahoo Web Search

Search results

  1. www.ukaachen.de › en › clinics-institutesAlpha1-Team - ukaachen

    We look forward to your inquiries and will be glad to answer all your questions: Univ.-Prof. Dr. med. Pavel Strnad. Lead Consultant and Scientific Advisor of the Alpha1-Liver Network and patient advocacy group Alpha1-Deutschland e.V. pstrnad ukaachen de. Dr. med. Malin Fromme. Resident physician.

  2. Pavel STRNAD | Cited by 12,029 | of University Hospital RWTH Aachen, Aachen | Read 404 publications | Contact Pavel STRNAD

  3. Univ.-Prof. Dr. med. Pavel Strnad, Leitender Oberarzt in der Medizinischen Klinik III und Leiter des Alpha1-Leberzentrums an der Uniklinik RWTH Aachen, hat mit den Kollegen Professor Jeffrey Teckman…

  4. Dec 7, 2016 · This Review describes the responses of the liver during sepsis, to highlight the mechanisms leading to liver injury during sepsis and to delineate the impaired defence against microbial infection...

  5. Jun 25, 2022 · Pavel Strnad, Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease, Alimentary Pharmacology & Therapeutics ...

  6. Apr 8, 2020 · Alpha1-antitrypsin (AAT) deficiency is one of the most common genetic diseases. Most persons carry two copies of the wild-type M allele of SERPINA1, which encodes AAT, and have normal circulating...

  7. loop.frontiersin.org › people › 28070Loop | Pavel Strnad

    Pavel Strnad is a full professor and leading physician at the University Hospital Aachen, Germany. In 2016, he was named one of the Rising Stars of the United European Gastroenterology. He is heading a European initiative for study of alpha1-antitrypsin deficiency-associated liver disease.